Kewaunee Scientific Corporation
KEQU · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -1.4% | -7.8% | 14.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 28.1% | 29.4% | 31.2% | 27.4% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 8.7% | 9.2% | 12.8% | 5.9% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 3.5% | 4.3% | 6.3% | 2% |
| EPS Diluted | 0.82 | 1.04 | 1.63 | 0.45 |
| % Growth | -21.2% | -36.2% | 262.2% | – |
| Operating Cash Flow | -$0 | $0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | $0 | -$0 |